|
| |
Articles
1-199 out of 199 article(s)
| Title |
Author |
Type |
Date |
Words |
| Alzheimer Disease - New Drugs, Markets and Companies - 2013. |
|
|
Mar 19, 2013 |
787 |
| Digestive juices blamed in shock: enzymes leaking from gut may have deadly consequences. |
Seppa, Nathan |
|
Feb 23, 2013 |
369 |
| Ganoderol B: a potent a-glucosidase inhibitor isolated from the fruiting body of Ganoderma lucidum. |
|
Brief article |
Feb 1, 2013 |
158 |
| Influence of concurrent medications on outcomes of men with prostate cancer included in the TAX 327 study. |
Niraula, Saroj; Pond, Greg; de Wit, Ronald; Eisenberger, Mario; Tannock, Ian F.; Joshua, Anthony M. |
Report |
Feb 1, 2013 |
3499 |
| Hyperparathyroidism - Analysis and Market Forecasts to 2019. |
|
|
Nov 13, 2012 |
1493 |
| Research and Markets: Global Enzyme Inhibitors Market 2011-2015 Report Discusses That the Patent Expiry of Top-Selling Drugs Is a Challenge for the Market. |
|
|
Oct 15, 2012 |
355 |
| Global Markets for Enzyme Inhibitors. |
|
|
Sep 6, 2012 |
5252 |
| Research and Markets: Alzheimer Disease - New Drugs, Markets and Companies - Updated 2012 Report. |
|
Report |
Sep 6, 2012 |
618 |
| Kinase Inhibitors: Global Markets -- Focus on the U.S. |
|
Company overview |
Sep 6, 2012 |
5589 |
| Kinase Inhibitors: Global Markets -- Focus on Asia. |
|
Company overview |
Sep 4, 2012 |
5463 |
| Kinase Inhibitors: Global Markets -- Focus on Europe. |
|
Company overview |
Sep 4, 2012 |
5491 |
| Kinase Inhibitors: Global Markets -- Focus on Emerging Markets. |
|
Company overview |
Sep 4, 2012 |
5497 |
| Global Markets for Enzyme Inhibitors -- Focus on the US. |
|
Company overview |
Sep 4, 2012 |
6476 |
| Global Markets for Enzyme Inhibitors -- Focus on Europe. |
|
Company overview |
Sep 4, 2012 |
6417 |
| Mildly reduced preoperative ejection fraction increases the risk of stroke in older adults undergoing Coronary Artery Bypass Grafting. |
Reyes, Bernardo; Trotter, Chase; Richards, Mark; Ladd, Jennifer; Broce, Mike; Kali, Maher; Groves, S |
Report |
Sep 1, 2012 |
3206 |
| Global Markets for Enzyme Inhibitors. |
|
Company overview |
Aug 28, 2012 |
6832 |
| Global Markets for Enzyme Inhibitors -- Focus on Emerging Markets. |
|
Company overview |
Aug 28, 2012 |
6500 |
| Synergetic effect of testosterone and phophodiesterase-5 inhibitors in hypogonadal men with erectile dysfunction: A systematic review. |
Alhathal, Naif; Elshal, Ahmed M.; Carrier, Serge |
Report |
Aug 1, 2012 |
4428 |
| First Clinical Data for BACE Inhibitor E2609 Showcased at International Alzheimer's Conference. |
|
Conference news |
Jul 23, 2012 |
1400 |
| Eisai Presents First Clinical Data for BACE Inhibitor E2609 at Alzheimer's Association International Conference 2012. |
|
Clinical report |
Jul 19, 2012 |
703 |
| Eisai to Present First Clinical Data for BACE Inhibitor E2609 at Alzheimer's Association International Conference 2012. |
|
Conference news |
Jul 13, 2012 |
358 |
| Newly discovered mechanism for chlorpyrifos effects on neurodevelopment. |
Potera, Carl |
Report |
Jul 1, 2012 |
1344 |
| Global Markets for Enzyme Inhibitors. |
|
Company overview |
Jun 26, 2012 |
6857 |
| Emerging Markets for Enzyme Inhibitors Surge, To Grow More Than 50% by 2016. |
|
|
Jun 25, 2012 |
863 |
| Prenatal exposure to insecticide chlorpyrifos may alter infants' brain structure. |
|
|
May 1, 2012 |
495 |
| Naturopathic management of infections of the heart and their sequelae. |
Mikolai, Jeremy; Wilner, Martin |
Clinical report |
May 1, 2012 |
8211 |
| Canadian Consensus Conference: The FDA decision on the use of 5ARIs. |
Klotz, Laurence; Chetner, Michael; Chin, Joseph; Finelli, Tony; Fleshner, Neil; Fradet, Yves; Golden |
Report |
Apr 1, 2012 |
3204 |
| Alzheimer Disease - New Drugs, Markets and Companies. |
|
|
Jan 3, 2012 |
6391 |
| Blood pressure meds may slow bone loss in men. |
|
Clinical report |
Jan 1, 2012 |
333 |
| Protective and ameliorative effects of mate (Ilex paraguariensis) on metabolic syndrome in TSOD mice. |
Husseina, Ghazi M.E.; Matsuda, Hisashi; Nakamura, Seikou; Akiyama, Toshihito; Tamura, Kouhei; Yoshik |
Report |
Dec 15, 2011 |
7183 |
| Virobay's Spectrum-Selective Cathepsin Inhibitor Shows Efficacy in Bone Cancer Model. |
|
|
Nov 14, 2011 |
722 |
| Research and Markets: Alzheimer Disease - New Drugs, Markets and Companies. |
|
|
Oct 24, 2011 |
627 |
| Research and Markets: Kinetics of Enzyme Action: Essential Principles for Drug Hunters. |
|
|
Oct 18, 2011 |
327 |
| Ganoderol B: a potent [alpha]-Glucosidase inhibitor isolated from the fruiting body of Ganoderma lucidum. |
Fatmawati, Sri; Shimizu, Kuniyoshi; Kondo, Ryuichiro |
Report |
Sep 15, 2011 |
2553 |
| Keynote address. |
|
Report |
Sep 1, 2011 |
215 |
| Dyax Announces Treatment of First Patient in Phase 2 Trial of Ecallantide for Acute Treatment of ACE Inhibitor-Induced Angioedema. |
|
|
Aug 4, 2011 |
1092 |
| Determinants of agricultural pesticide concentrations in carpet dust. |
Gunier, Robert B.; Ward, Mary H.; Airola, Matthew; Bell, Erin M.; Colt, Joanne; Nishioka, Marcia; Me |
Report |
Jul 1, 2011 |
7813 |
| The role of Ginkgo biloba extract in the integrative management of dementia. |
Wheat, Janelle M.; Currie, Geoffrey M.; Kiat, Hosen |
Report |
Jun 22, 2011 |
6317 |
| Biomarker of exposure for chlorpyrifos. |
|
Brief article |
Jun 1, 2011 |
120 |
| Biomarkers of chlorpyrifos exposure and effect in Egyptian cotton field workers. |
Farahat, Fayssal M.; Ellison, Corie A.; Bonner, Matthew R.; McGarrigle, Barbara P.; Crane, Alice L.; |
Report |
Jun 1, 2011 |
6699 |
| Acoustic detection of arthropod infestation of grape roots: scouting for grape root borer (Lepidoptera: Sesiidae). |
Sanders, William R.; Mankin, R.W.; Liburd, Oscar E.; Stelinski, Lukasz L. |
Report |
Jun 1, 2011 |
4303 |
| Complexity of prescriptions impairs adherence. |
Moon, Mary Ann |
|
Jun 1, 2011 |
876 |
| Ellagitannins from Phyllanthus muellerianus (Kuntze) Exell.: geraniin and furosin stimulate cellular activity, differentiation and collagen synthesis of human skin keratinocytes and dermal fibroblasts. |
Agyare, Christian; Lechtenberg, Matthias; Deters, Alexandra; Petereit, Frank; Hensel, Andreas |
|
May 15, 2011 |
6713 |
| Reportlinker Adds Alzheimer disease - New drugs, markets and companies. |
|
|
May 2, 2011 |
757 |
| Efficient synthesis of a novel class of 1, [omega]-bis(triazoles) and 1, [omega]-bis[[l,2,4]triazolo[3,4-b][l,3,4]thiadiazoles] with potential antimicrobial activity. |
Khalil, Nasser S.A.M. |
|
May 1, 2011 |
14937 |
| Reportlinker Adds Alzheimer Disease - New Drugs, Markets and Companies. |
|
|
Apr 4, 2011 |
817 |
| Landmark Ruling Comes Into Effect: Treatment now Available for People With Mild Alzheimer's at Time of Diagnosis. |
|
|
Mar 22, 2011 |
1521 |
| Jury out on scleroderma renal crisis prophylaxis. |
Mahoney, Diana |
Clinical report |
Mar 15, 2011 |
593 |
| Stop that clot: haemostasis and anticoagulation: this is the first in a series of clinical articles Kai Tiaki Nursing New Zealand is publishing to provide a convenient way for nurses to earn continuing professional development hours. |
Casey, Georgina |
Report |
Feb 1, 2011 |
4569 |
| The impact of Medicare Part D on medication treatment of hypertension. |
Zhang, Yuting; Donohue, Julie M.; Lave, Judith R.; Gellad, Walid F. |
Report |
Feb 1, 2011 |
5585 |
| Predicting cyclooxygenase inhibition by three-dimensional pharmacophoric profiling. Part II: identification of enzyme inhibitors from Prasaplai, a Thai traditional medicine. |
Waltenberger, Birgit; Schuster, Daniela; Paramapojn, Sompol; Gritsanapan, Wandee; Wolber, Gerhard; R |
Report |
Jan 15, 2011 |
7359 |
| Research and Markets: Alzheimer Disease - An Updated Report on New Drugs, Markets and Companies. |
|
Report |
Jan 4, 2011 |
617 |
| Control and treatment profiles of 70,889 adult type 2 diabetes mellitus patients in Malaysia--a cross sectional survey in 2009. |
Mastura, Ismail; Chew, Boon How; Lee, Ping Yein; Cheong, Ai Theng; Sazlina, Shariff Ghazali; Jamaiya |
|
Jan 1, 2011 |
6171 |
| Cancer Targeted Technology Enters into a Research and License Option Agreement with Bayer Pharma AG to Advance a Cancer PET Imaging Agent toward Clinical Trials. |
|
|
Dec 14, 2010 |
397 |
| Boehringer Ingelheim Initiates Phase III Clinical Trial With Afatinib in Advanced Breast Cancer. |
|
|
Dec 8, 2010 |
1312 |
| U.S. Patent Issued for New Method for Treating Cognitive Disorders. |
|
|
Dec 6, 2010 |
571 |
| Surprisingly Few Surveyed Neurologists in the EU5 Are Familiar With Late-Stage Emerging Therapies for Alzheimer's Disease. |
|
|
Nov 15, 2010 |
774 |
| Epizyme Awarded $733,000 Grant under Qualified Therapeutic Discovery Project Program. |
|
|
Nov 3, 2010 |
393 |
| Effect of carbamate-pesticides and sewage--sludge on growth and trace elements concentration in wheat plants. |
Bansal, O.P. |
|
Nov 1, 2010 |
4488 |
| Milestone Ruling for Alzheimer's Disease Patients Announced. |
|
|
Oct 6, 2010 |
1498 |
| New and established targets for the treatment of breast cancer. |
Man, Yik L.; Filipovic, Aleksandra; Stebbing, Justin; Giamas, Georgios |
|
Sep 1, 2010 |
3380 |
| Cardiac health following drug treatment for breast cancer. |
Verrill, Mark |
|
Jul 1, 2010 |
3407 |
| Cholinesterase depression and its association with pesticide exposure across the agricultural season among Latino farmworkers in North Carolina. |
Quandt, Sara A.; Chen, Haiying; Grzywacz, Joseph G.; Vallejos, Quirina M.; Galvan, Leonardo; Arcury, |
Report |
May 1, 2010 |
5700 |
| Association between renin-angiotensin-aldosterone system blockers and postoperative atrial fibrillation in patients with mild and moderate left ventricular dysfunction/Hafif ve orta derecede sol ventrikul disfonksiyonu olan hastalarda renin-anjiyotensin-aldosteron sistem blokerleri ile kalp cerrahisi sonrasi gelisen atrial fibrilasyon arasindaki iliski. |
Ozaydin, Mehmet; Varol, Ercan; Turker, Yasin; Peker, Oktay; Erdogan, Dogan; Dogan, Abdullah; Ibrisim |
Clinical report |
Apr 1, 2010 |
4945 |
| Pesticide chlorpyrifos associated with childhood developmental delays. |
|
|
Mar 21, 2010 |
465 |
| Acetylon Licenses Powerful Discovery Methodology and Platform from Harvard University and the Dana-Farber Cancer Institute for Development of Further Next-Generation Class II-Selective HDAC Inhibitor Compounds. |
|
|
Mar 8, 2010 |
1089 |
| Acetylcholinesterase enzyme inhibitory potential of standardized extract of Trigonella foenum graecum L and its constituents. |
SatheeshKumar, N.; Mukherjee, Pulok K.; Bhadra, S.; Saha, B.P. |
Clinical report |
Mar 1, 2010 |
2989 |
| Beta-lactamase inhibitory component from the roots of Fissistigma cavaleriei. |
Yang, Zaichang; Niu, Yule; Le, Yi; Ma, Xiaoyan; Qiao, Chong |
Report |
Feb 1, 2010 |
1987 |
| Silver impairs neurodevelopment: studies in PC12 cells. |
Powers, Christina M.; Wrench, Nicola; Ryde, Ian T.; Smith, Amanda M.; Seidler, Frederic J.; Slotkin, |
Report |
Jan 1, 2010 |
6920 |
| The implications of using a physiologically based pharmacokinetic (PBPK) model for pesticide risk assessment. |
Lu, Chensheng; Holbrook, Christina M.; Andres, Leo M. |
Report |
Jan 1, 2010 |
7046 |
| Is the epidermal growth factor receptor status in lung cancers reflected in clinicopathologic features? |
Inamura, Kentaro; Ninomiya, Hironori; Ishikawa, Yuichi; Matsubara, Osamu |
Report |
Jan 1, 2010 |
4681 |
| Well-water consumption and Parkinson's disease in rural California. |
Gatto, Nicole M.; Cockburn, Myles; Bronstein, Jeff; Manthripragada, Angelika D.; Ritz, Beate |
Report |
Dec 1, 2009 |
8686 |
| Nycomed and Forest Laboratories to Collaborate on Daxas[R] (roflumilast) for COPD. |
|
|
Aug 10, 2009 |
1286 |
| Inkjet printer technology may be used to make toxin-detecting biosensors. |
|
|
Jul 14, 2009 |
357 |
| Comparison of methods for the extraction of genomic DNA from aerobic digest. |
Blankinship, Lisa Ann |
Report |
Jul 1, 2009 |
5881 |
| Updates on lupus and pregnancy. |
|
|
Jul 1, 2009 |
4286 |
| Interim Analysis of Long-Term Data with ONGLYZA,ao (saxagliptin) When Added to Metformin in People with Inadequately Controlled Type 2 Diabetes Present. |
|
|
Jun 7, 2009 |
1826 |
| Interim Analysis of Long-Term Data with ONGLYZA[TM] (saxagliptin) When Added to Metformin in People with Inadequately Controlled Type 2 Diabetes Presented at ADA Annual Scientific Sessions. |
|
|
Jun 6, 2009 |
1722 |
| Thyroid carcinoma recommendations updated. |
McNamara, Damian |
|
Jun 1, 2009 |
934 |
| The effect of the content of the knowledge on adherence to medication in hypertensive patients/Hipertansiyonlu hastalarda bilgi iceriginin ilac tedavisi uyumuna etkisi. |
Karaeren, Hayrettin; Yokusoglu, Mehmet; Uzun, Senay; Baysan, Oben; Koz, Cem; Kara, Belguzar; Kirilma |
Clinical report |
Jun 1, 2009 |
3429 |
| Morphogenomics and morphoproteomics: a role for anatomic pathology in personalized medicine. |
Brown, Robert E. |
Report |
Apr 1, 2009 |
9120 |
| 1,6-0, 0-diacetylbritannilactones inhibits I[kappa]B kinase [beta]-dependent NF-[kappa]B activation. |
Liu, Yue-Ping; Wen, Jin-Kun; Wu, Yi-Bing; Zhang, Jia; Zheng, Bin; Zhang, Di-Qun; Han, Mei |
Report |
Mar 1, 2009 |
2735 |
| Inhibitory effect of rhetsinine isolated from Evodia rutaecarpa on aldose reductase activity. |
Kato, A.; Yasuko, H.; Goto, H.; Hollinshead, J.; Nash, R.J.; Adachi, I. |
Report |
Mar 1, 2009 |
2492 |
| Research and Markets: Analyse Profiles of 134 Companies Involved in Developing Diagnostics and Therapeutics for Alzheimer's Disease Are Presented along with 101 Collaborations. |
|
|
Feb 5, 2009 |
528 |
| A Phase I study of full-dose gemcitabine and regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer. |
Carrato, Alfredo; Guillen-Ponce, Carmen |
|
Dec 1, 2008 |
866 |
| A Comprehensive Analysis of the Production and Marketing of Chlorpyrifos in China: Understand the Current Market, Issues & Forecasts to 2013. |
|
|
Oct 24, 2008 |
344 |
| Agency: Chemicals a danger to salmon. |
|
|
Aug 6, 2008 |
777 |
| Tracheal diverticulum: a rare finding in a patient with worsening chronic cough. |
Danielson, Gregory P.; Jedlovszky, Veronika; Landrigan, Gary P. |
Clinical report |
Aug 1, 2008 |
1150 |
| Bristol-Myers Squibb and AstraZeneca Submit New Drug Application in the United States and Marketing Authorization Application in Europe for ONGLYZA(TM) (saxagliptin) for the Treatment of Type 2 Diabetes. |
|
|
Jul 23, 2008 |
631 |
| ONGLYZA(TM) (saxagliptin) Demonstrated Significant Reductions in Key Measures of Glucose Control in Treatment Naive People with Type 2 Diabetes. |
|
|
Jun 7, 2008 |
1754 |
| Alzheimer's--potential cure. |
Bateman, Chris |
Brief article |
Jun 1, 2008 |
80 |
| ARIAD Initiates Phase 1 Clinical Trial of its Investigational Oral Multi-Targeted Kinase Inhibitor, AP24534, in Patients with Hematological Cancers. |
|
|
May 22, 2008 |
1415 |
| Plexxikon Announces Preclinical Data Demonstrating Dramatic Improvement in Key Symptoms of Polycystic Kidney Disease. |
|
|
May 21, 2008 |
991 |
| Gloucester Pharmaceuticals Announces Positive Results from Phase 2b Registration Trial of Romidepsin in Refractory CTCL. |
|
Financial report |
May 19, 2008 |
1047 |
| VioQuest Pharmaceuticals Announces Upcoming Lenocta(TM) Oral Presentation at the American Society of Clinical Oncology Annual Meeting. |
|
|
May 19, 2008 |
782 |
| Lev Pharmaceuticals to Present at the Rodman and Renshaw 5th Annual Global Healthcare Conference. |
|
Conference news |
May 13, 2008 |
588 |
| Results Published in JACC Show Clinical Advantage of Switching to Angiomax from Heparin in Acute Coronary Syndrome Patients Undergoing Early Invasive Treatment. |
|
|
May 5, 2008 |
1187 |
| Lev Announces FDA Advisory Committee Unanimously Recommends Approval of Cinryze(TM) for Hereditary Angioedema. |
|
|
May 2, 2008 |
1394 |
| Coversyl(R) Protects Hypertensive Patients Against New-Onset Diabetes. |
|
|
May 1, 2008 |
1115 |
| Potential New Oral Treatment May Revolutionise Management of Deadly Hepatitis C Virus. |
|
|
Apr 26, 2008 |
1089 |
| Data Suggests Promising Overall Survival and Progression-Free Survival With VARGATEF(TM) (BIBF 1120). |
|
Clinical report |
Apr 25, 2008 |
1498 |
| Telaprevir-Based PROVE Studies Show Significantly Higher SVR Rates in Treatment-Naive Genotype 1 Hepatitis C Patients in Half the Time of Current Treatments. |
|
|
Apr 23, 2008 |
1706 |
| Nereus Pharmaceuticals Initiates Combination Clinical Trial for Proteasome Inhibitor NPI-0052 in Solid Tumors. |
|
|
Apr 18, 2008 |
605 |
| VioQuest Pharmaceuticals' Novel Akt Inhibitor VQD-002 is Synergistic with Various Cancer Therapies in Preclinical Studies. |
|
|
Apr 16, 2008 |
1033 |
| Cyclacel Pharmaceuticals Presents Insights into the Mechanisms of Its Cell Cycle Inhibitor Drugs. |
|
|
Apr 16, 2008 |
1096 |
| Lev Pharmaceuticals Announces Submission of Complete Response to FDA for Cinryze(TM) for Hereditary Angioedema. |
|
|
Apr 15, 2008 |
778 |
| Lev Pharmaceuticals Announces Agreement to Sell Intermediate Plasma Products to Biotest AG. |
|
|
Apr 15, 2008 |
572 |
| Curis Announces Preclinical Efficacy Data for CUDC-101 at AACR Annual Meeting 2008. |
|
|
Apr 14, 2008 |
1004 |
| ArQule Summarizes Abstracts Presented at AACR. |
|
|
Apr 14, 2008 |
639 |
| Avalon Pharmaceuticals Identifies Small Molecule Inhibitors of the Aurora/Centrosome Cancer Pathway that Block PLK3 Protein Function. |
|
|
Apr 14, 2008 |
405 |
| AVEO Pharmaceuticals' Novel Triple VEGF Receptor Inhibitor Shows Tumor Regression in Patients with Advanced Renal Cancer; Clinical Activity and Tolerability in other Solid Tumors including Colon and Lung Cancers. |
|
|
Apr 14, 2008 |
1043 |
| U3 Pharma Achieves Preclinical Proof of Concept for U3-1287 (AMG 888). |
|
|
Apr 13, 2008 |
434 |
| Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets. |
|
|
Apr 11, 2008 |
1229 |
| New Clinical Data on AVEO Pharmaceuticals' Investigational Triple VEGFR Small Molecule Inhibitor AV-951 to be Presented at AACR Annual Meeting. |
|
|
Apr 8, 2008 |
586 |
| Cyclacel Pharmaceuticals Announces Multiple Presentations at American Association of Cancer Research Annual Meeting. |
|
|
Apr 7, 2008 |
767 |
| Curis Announces Presentation at the 235th American Chemical Society National Meeting. |
|
|
Apr 7, 2008 |
1038 |
| Avalon Pharmaceuticals to Present at the American Association for Cancer Research 2008 Annual Meeting. |
|
|
Apr 7, 2008 |
394 |
| Metabasis Therapeutics Presents the Discovery of Its Second-Generation FBPase Inhibitor, MB07803, at the 235th American Chemical Society National Meeting. |
|
|
Apr 7, 2008 |
1071 |
| Duodenogastroesophageal reflux and its effect on extraesophageal tissues: a review. |
Blumin, Joel H.; Merati, Albert L.; Toohill, Robert J. |
|
Apr 1, 2008 |
3087 |
| Vertex Pharmaceuticals Announces Acceptance of Late-Breaker Abstract on Telaprevir, Investigational HCV Protease Inhibitor, for Presentation at EASL Annual Meeting. |
|
|
Mar 31, 2008 |
551 |
| BWA Water Additives Introduces Belcor(R) 585 - A Unique Multifunctional Corrosion Inhibitor for Industrial Water Systems. |
|
|
Mar 31, 2008 |
343 |
| Novel Oral Anticoagulant Pradaxa(R) (dabigatran etexilate) Approved by the European Commission. |
|
|
Mar 27, 2008 |
1533 |
| Lev Presents Results of Phase III Study Supporting Safety and Efficacy of Cinryze(TM) (C1 inhibitor) as Prophylactic Therapy for HAE. |
|
|
Mar 18, 2008 |
1280 |
| Lev Pharmaceuticals to Present at the Cowen and Company 28th Annual Healthcare Conference. |
|
Conference news |
Mar 14, 2008 |
275 |
| Lev Announces FDA's Blood Products Advisory Committee to Review Cinryze (TM) (C1 inhibitor). |
|
|
Mar 13, 2008 |
950 |
| ArQule Enrolls First Patient in Phase 1/2 Clinical Trial Program of ARQ 197 in Non-Small Cell Lung Cancer. |
|
|
Mar 13, 2008 |
1081 |
| Vertex Pharmaceuticals and Tibotec Announce Start of Phase 3 'ADVANCE' Study with Telaprevir in Treatment-Naive, Genotype 1 HCV Patients. |
|
Clinical report |
Mar 13, 2008 |
1345 |
| Clinical Data on Lenocta(TM), a Protein Tyrosine Phosphatase Inhibitor in Development at VioQuest Pharmaceuticals, Accepted for Oral Presentation at ASCO. |
|
|
Mar 10, 2008 |
762 |
| The Global Market for Angiogenesis Therapeutic Products is Projected to Reach About US$ 22 Billion by 2012. |
|
|
Mar 8, 2008 |
507 |
| Array BioPharma Announces Positive Phase 2 Top-Line Results in Inflammatory Pain Clinical Trial. |
|
|
Mar 3, 2008 |
1036 |
| Inhibiting 5-lipoxygenase promotes prostate cancer cell death. |
Kiefer, Dale |
|
Jan 1, 2008 |
285 |
| Clinical implications of resistance patterns against HBV-polymerase inhibitors for the treatment of chronic hepatitis B. |
Mauss, Stefan |
|
Dec 1, 2007 |
2155 |
| Chronic kidney disease requires aggressive, integrated care. |
Wendling, Patrice |
|
Oct 1, 2007 |
408 |
| Lipid peroxidation, cyclooxygenase enzyme and tumor cell proliferation inhibitory compounds in Cornus kousa fruits. |
Vareed, Shaiju K.; Schutzki, Robert E.; Nair, Muraleedharan G. |
Clinical report |
Oct 1, 2007 |
2004 |
| Boehringer Ingelheim Announces First International Head-to-Head Trial of Aptivus(R) (tipranavir) versus darunavir in Treatment-Experienced HIV-Positive Patients. |
|
|
Jul 24, 2007 |
1168 |
| Abbott Submits E.U. and U.S. Regulatory Filings for New Lower-Strength Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) Tablet Suitable for Pediatric Use in HIV/AIDS. |
|
|
Jul 20, 2007 |
1666 |
| N-terminal pro-B-type natriuretic peptide predicts total and cardiovascular mortality in individuals with or without stable coronary artery disease: the Ludwigshafen risk and cardiovascular health study. |
Marz, Winfried; Tiran, Beate; Seelhorst, Ursula; Wellnitz, Britta; Bauersachs, Johann; Winkelmann, B |
Clinical report |
Jun 1, 2007 |
7682 |
| Gilead Announces 24-Week Results from Phase II Study of Investigational HIV Integrase Inhibitor GS 9137. |
|
|
Mar 1, 2007 |
1490 |
| Efficacy and economics of topical calcineurin inhibitors for the treatment of atopic dermatitis. |
Abramovits, W.; Hung, P.; Tong, K.B. |
Brief article |
Jan 1, 2007 |
267 |
| TNF inhibitors may reduce stroke, MI. |
|
|
Aug 15, 2006 |
670 |
| Getting back at celiac: enzyme treatment might stem wheat intolerance. |
Brownlee, C. |
|
Jul 1, 2006 |
497 |
| Duke University obtains United States patent. |
|
Brief article |
Jul 1, 2006 |
96 |
| Hepatotoxicity risk of statins. |
Evans, Jeff |
Brief Article |
Jun 1, 2004 |
159 |
| Compounds trigger tumor-cell suicide. |
Travis, John |
|
Jan 24, 2004 |
478 |
| Amgen and Biovitrum sign metobolic disease license agreement. |
|
|
Sep 1, 2003 |
599 |
| Enzyme inhibitor cuts glucose in type 2 diabetes; taken daily at breakfast. |
McNamara, Damian |
Brief Article |
Aug 1, 2003 |
267 |
| Inhibitory activity of xanthine oxidase and superoxide-scavenging activity in some taxa of the lichen family Graphidaceae. |
Behera, B.C.; Adawadkar, B.; Makhija, U. |
|
Jul 1, 2003 |
4798 |
| [alpha]-Asarone inhibits HMG-CoA reductase, lowers serum LDL-cholesterol levels and reduces biliary CSI in hypercholesterolemic rats. |
Rodriguez-Paez, L.; Juarez-Sanchez, M.; Antunez-Solis, J.; Baeza, I.; Wong, C. |
|
Jun 1, 2003 |
4736 |
| Quantitative analysis of ornithine decarboxylase MRNA by reverse transcription-PCR with the LightCycler system. |
Orta, Xavi; Balsells, Joaquin; Olsina, Jorge; Venereo, Yusimy; Segovia-Silvestre, Toni; Farriol, Mir |
|
Oct 1, 2002 |
2317 |
| Age-related underutilization of angiotensin-converting enzyme inhibitors in older hospitalized heart failure patients. |
Howard, George |
|
Jul 1, 2002 |
5810 |
| New drugs to debut for erectile dysfunction. (Vardenafil, Tadalafil). |
Norton, Patrice G.W. |
Brief Article |
Jul 1, 2002 |
154 |
| New HIV drugs in the pipeline: drug companies have dozens of new anti-HIV drugs under study, with many advantages--and a few drawbacks--compared with existing medications. (Health Update). |
Adams, Bob |
Statistical Data Included |
May 28, 2002 |
1445 |
| 3-Dimensional receives patent protection. |
|
Brief Article |
Sep 1, 2001 |
262 |
| Measurement of plasma renin activity with use of HPLC-electrospray-tandem mass spectrometry. |
Fredline, Victoria F.; Kovacs, Eva M.; Taylor, Paul J.; Johnson, Anthony G. |
|
May 1, 1999 |
4167 |
| Drugs tackle cancer in unexpected way. |
J.T. |
Brief Article |
Apr 10, 1999 |
180 |
| Early Results of Clinical Trial Data in Diabetic Eye Study Are Promising, Joslin Researchers Report. |
|
|
Oct 22, 1998 |
927 |
| Testing for natural aflatoxin inhibitors. |
Hardin, Ben |
|
Jul 1, 1998 |
446 |
| FibroGen Reports Key Advances in Scarring and Regeneration. |
|
Article |
Jun 22, 1998 |
370 |
| Triangle Pharmaceuticals Announces the Re-Initiation of Trials with DMP-450 |
|
|
Dec 22, 1997 |
443 |
| AIDS Vaccine Effective in Animal Tests; Human HGP-30 Antibodies Shown to Recognize HIV Subtypes |
|
|
Dec 10, 1997 |
817 |
| AIDS Vaccine Effective in Animal Tests; Human HGP-30 Antibodies Shown to Recognize HIV Subtypes |
|
|
Dec 10, 1997 |
833 |
| Alteon and Genentech to Collaborate on Therapy for Diabetic Complications |
|
|
Dec 4, 1997 |
1068 |
| Peptimmune Acquires Option to HIV Therapeutic Vaccine Technology From Massachusetts General Hospital |
|
|
Dec 2, 1997 |
462 |
| Patients With Hereditary Lung Disease Eligible for Treatment in Clinical Study |
|
|
Dec 1, 1997 |
294 |
| Bristol-Myers Squibb and Arris Pharmaceutical to Develop Hepatitis C Inhibitors |
|
|
Dec 1, 1997 |
652 |
| Forest Laboratories Announces the Filing of a New Drug Application For Synapton for the Treatment of Alzheimer's Disease |
|
|
Nov 18, 1997 |
297 |
| Bristol-Myers Squibb Statement Regarding the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study |
|
|
Nov 12, 1997 |
531 |
| FDA Grants Roche Marketing Clearance for FORTOVASE(TM) (saquinavir) |
|
|
Nov 10, 1997 |
1302 |
| Heska Enters Development Collaboration With CollaGenex for Pharmaceutical Products for Treatment of Inflammatory Diseases |
|
|
Nov 5, 1997 |
676 |
| LXR Biotechnology Inc. Receives FDA Permission to Commence Pivotal Clinical Trial for Heart Preservation Solution(z) |
|
|
Nov 5, 1997 |
504 |
| Medizone International To Move Forward With Human Clinical Trials |
|
|
Oct 21, 1997 |
515 |
| Aronex Pharmaceuticals Awarded $1.1 Million In Grants |
|
|
Oct 20, 1997 |
481 |
| Corvas Announces Issuance of U.S. Patents on Serine Protease Inhibitors |
|
|
Oct 20, 1997 |
608 |
| CoCensys' Apoptosis Program Garners SBIR Grant |
|
|
Oct 16, 1997 |
377 |
| Vertex Pharmaceuticals Reports Encouraging Preliminary Data from Phase II Clinical Study with HIV Protease Inhibitor 141W94 |
|
|
Oct 13, 1997 |
926 |
| Agouron Reports Anticancer Collaboration With U.K. Organizations; Agouron to Immediately Optimize Lead Compounds |
|
|
Oct 2, 1997 |
510 |
| VIRAMUNE Triple Combo Reduces Viral Load Below Limit of Detection In 60 Percent 0f Advanced-Stage HIV-1 Patients |
|
|
Sep 29, 1997 |
534 |
| Viramune Triple Therapy Shows Suppression of HIV After One Year, 7 Months - Over 50% of Patients Below Limit of Detection - |
|
|
Sep 29, 1997 |
530 |
| Aronex Presents Results for Integrase Inhibitor Zintevir(TM) at ICAAC Conference |
|
|
Sep 29, 1997 |
500 |
| New Studies with Crixivan Presented at ICAAC: Crixivan in Triple Therapy Lowered HIV to Undetectable Levels for Two Years in Approximately 80 Percent of Patients in Merck Study 035 |
|
|
Sep 29, 1997 |
1489 |
| Triangle Pharmaceuticals Reports Data on Increased Dosages of MKC-442 in HIV-Infected Patients |
|
|
Sep 29, 1997 |
664 |
| Agouron's VIRACEPT Exhibits Anti-HIV Potency After 12 Months Additional Results Reported at International Meeting |
|
|
Sep 29, 1997 |
4913 |
| Investigational Protease Inhibitor Fortovase(TM) (saquinavir) Compares Favorably in First Head-to-Head Study |
|
|
Sep 29, 1997 |
790 |
| Vertex and Glaxo Wellcome Begin Third Phase III Pivotal Trial with HIV Protease Inhibitor 141W94 (VX-478) |
|
|
Sep 29, 1997 |
928 |
| Dyax Corp. Issued U.S. Patent Covering Novel Elastase Inhibitors |
|
|
Sep 25, 1997 |
454 |
| The Immune Response Corporation Presents REMUNE(TM) Data at the Second Annual Institute of Human Virology Meeting |
|
|
Sep 22, 1997 |
553 |
| CEL-SCI Corporation and AIDS ReSEARCH Alliance Announce Results of HGP-30 AIDS Vaccine Study, Plan Further Study |
|
|
Sep 17, 1997 |
493 |
| Tredegar's Molecumetics Subsidiary, Teijin to Collaborate On Anti-Coagulant Drug Research |
|
|
Sep 10, 1997 |
481 |
| CollaGenex Pharmaceuticals Hires Former P&G Marketing Group For U.S. Launch Of Periostat |
|
|
Feb 13, 1997 |
660 |
| FDA APPROVES FIRST PROTEASE INHIBITOR DRUG FOR TREATMENT OF HIV |
|
|
Dec 7, 1995 |
901 |
| FDA CLEARS FIRST IN NEW CLASS OF AIDS DRUGS CALLED HIV PROTEASE INHIBITORS |
|
|
Dec 7, 1995 |
796 |
| Bak, the Bcl-2-homologous antagonist/killer, a critical modulator of apoptosis in human disease. |
Barr, Philip J.; Kiefer, Michael C. |
|
Nov 1, 1995 |
766 |
| Backup digestive enzyme rescues insects. |
Adler, T. |
Brief Article |
Aug 19, 1995 |
465 |
| AGOURON REPORTS NOVEL ANTI-HIV COMPOUNDS |
|
|
Oct 20, 1993 |
486 |
| Plants that fight back. |
|
|
Jun 1, 1993 |
445 |
| Enzyme blocker cools inflammatory reaction. |
Raloff, J. |
|
May 5, 1990 |
600 |
| Enzyme blockers slay AIDS 'giant.' |
Edwards, Diane D. |
|
Nov 7, 1987 |
400 |
| Muscular dystrophy: defective inhibitor? |
|
|
Jan 17, 1987 |
346 |
| Why did my sister get lung cancer? When a non-smoker who hasn't lived or worked around smokers gets primary lung cancer, could it be because of radon gas in the home and-or a hereditary alpha 1 antitrypsin deficiency? |
SerVaas, Cory |
|
Jan 1, 1987 |
2940 |
|
